Engineers at the University of California San Diego have developed neutrophil “nanosponges” that can safely absorb and neutralize a variety of proteins that play a role in the progression of rheumatoid arthritis. Injections of these nanosponges effectively treated severe rheumatoid arthritis in two mouse models. Administering the nanosponges early on also prevented the disease from developing.
The work is published Sept. 3 in Nature Nanotechnology.
“Nanosponges are a new paradigm of treatment to block pathological molecules from triggering disease in the body,” said senior author Liangfang Zhang, a nanoengineering professor at the UC San Diego Jacobs School of Engineering. “Rather than creating treatments to block a few specific types of pathological molecules, we are developing a platform that can block a broad spectrum of them, and this way we can treat and prevent disease more effectively and efficiently.”
This work is one of the latest examples of therapeutic nanosponges developed by Zhang’s lab. Zhang, who is also affiliated with the Institute of Engineering in Medicine and Moores Cancer Center at UC San Diego, and his team previously developed red blood cell nanosponges to combat and prevent MRSA infections and macrophage nanosponges to treat and manage sepsis.
The new nanosponges are nanoparticles of biodegradable polymer coated with the cell membranes of neutrophils, a type of white blood cell.
Neutrophils are among the immune system’s first responders against invading pathogens. They are also known to play a role in the development of rheumatoid arthritis, a chronic autoimmune disease that causes painful inflammation in the joints and can ultimately lead to damage of cartilage and bone tissue.
When rheumatoid arthritis develops, cells in the joints produce inflammatory proteins called cytokines. Release of cytokines signals neutrophils to enter the joints. Once there, cytokines bind to receptors on the neutrophil surfaces, activating them to release more cytokines, which in turn draws more neutrophils to the joints and so on.
The nanosponges essentially nip this inflammatory cascade in the bud. By acting as tiny neutrophil decoys, they intercept cytokines and stop them from signaling even more neutrophils to the joints, reducing inflammation and joint damage.
These nanosponges offer a promising alternative to current treatments for rheumatoid arthritis. Some monoclonal antibody drugs, for example, have helped patients manage symptoms of the disease, but they work by neutralizing only specific types of cytokines. This is not sufficient to treat the disease, said Zhang, because there are so many different types of cytokines and pathological molecules involved.
“Neutralizing just one or two types might not be as effective. So our approach is to take neutrophil cell membranes, which naturally have receptors to bind all these different types of cytokines, and use them to manage an entire population of inflammatory molecules,” said Zhang.
“This strategy removes the need to identify specific cytokines or inflammatory signals in the process. Using entire neutrophil cell membranes, we’re cutting off all these inflammatory signals at once,” said first author Qiangzhe Zhang, a Ph.D. student in Professor Liangfang Zhang’s research group at UC San Diego.
To make the neutrophil nanosponges, the researchers first developed a method to separate neutrophils from whole blood. They then processed the cells in a solution that causes them to swell and burst, leaving the membranes behind. The membranes were then broken up into much smaller pieces. Mixing them with ball-shaped nanoparticles made of biodegradable polymer fused the neutrophil cell membranes onto the nanoparticle surfaces.
“One of the major challenges of this work was streamlining this entire process, from isolating neutrophils from blood to removing the membranes, and making this process repeatable. We spent a lot of time figuring this out and eventually created a consistent neutrophil nanosponge production line,” said Qiangzhe Zhang.
In mouse models of severe rheumatoid arthritis, injecting nanosponges in inflamed joints led to reduced swelling and protected cartilage from further damage. The nanosponges performed just as well as treatments in which mice were administered a high dose of monoclonal antibodies.
The nanosponges also worked as a preventive treatment when administered prior to inducing the disease in another group of mice.
Professor Liangfang Zhang cautions that the nanosponge treatment does not eliminate the disease. “We are basically able to manage the disease. It’s not completely gone. But swelling is greatly reduced and cartilage damage is minimized,” he said.
The team hopes to one day see their work in clinical trials.
Learn more: Neutrophil Nanosponges Soak up Proteins That Promote Rheumatoid Arthritis
The Latest on: Rheumatoid arthritis
[google_news title=”” keyword=”rheumatoid arthritis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Reumatoid arthritis
- Eating these foods could stop you getting diabetes, heart disease, arthritis and moreon May 17, 2024 at 1:58 am
Research has shown too much inflammation in the body can trigger various chronic illnesses, such as obesity, type 2 diabetes, and dementia ...
- AKP-11 by Akaal Pharma for Arthritis: Likelihood of Approvalon May 16, 2024 at 8:06 pm
AKP-11 is under clinical development by Akaal Pharma and currently in Phase II for Arthritis. According to GlobalData, Phase II drugs for Arthritis have a 67% phase transition success rate (PTSR) ...
- Oxford BioDynamics and Kings College London to advance rheumatoid arthritis treatmenton May 16, 2024 at 4:20 am
Oxford BioDynamics (OBD) and King’s College London (KCL) have partnered to use OBD’s EpiSwitch technology to identify patients at risk of rheumatoid arthritis (RA) who can benefit from abatacept ...
- In RA Treatment, Don't Overlook Underlying CV Riskson May 16, 2024 at 12:21 am
Disease-modifying antirheumatic drugs can reduce some cardiovascular risk in patients with rheumatoid arthritis, but questions remain if that's enough when statin use lags.
- Six superfoods to ease joint pain as experts share 'ultimate' arthritis dieton May 15, 2024 at 7:44 pm
One study found that over a 15-year period, men and women who consumed the most nuts had a 51 percent lower risk of dying from an inflammatory disease (like rheumatoid arthritis) compared to those who ...
- 'I'm a Doctor Who Treats Arthritis—This Is the Breakfast I Eat Almost Every Day for Joint Health'on May 13, 2024 at 3:25 am
The anti-inflammatory smoothie. Blend Spinach, banana, almond milk, turmeric, ginger and a scoop of protein powder, "This smoothie is packed with antioxidants and anti-inflammatory compounds, ...
- Nipocalimab's Unique Mechanism Gets Second Chance in Rheumatoid Arthritison May 13, 2024 at 2:58 am
The trial proved that nipocalimab reduced IgG antibodies, including anti-citrullinated protein autoantibodies, but the primary endpoint was missed.
- Six foods that could ease arthritis pain in the 'ultimate' dieton May 12, 2024 at 11:59 pm
Fruits and veggies rich in vitamin C and vitamin K are also beneficial for easing arthritis pain. According to the foundation, olive oil is loaded with heart-healthy fats, as well as oleocanthal, ...
- Ask A Doctor: How Can You Tell If You Have Rheumatoid Arthritis?on May 11, 2024 at 2:28 pm
Expert opinion from Robert H. Shmerling M.D. Senior Faculty Editor, Harvard Health Publishing · 30 years of experience · USA Symptoms of rheumatoid arthritis vary from person to person but typically ...
- Rheumatoid Arthritis Treatment Linked with Lower Dementia Riskon May 11, 2024 at 1:01 am
Dementia risk is decreased among patients with rheumatoid arthritis who are treated with biologic disease-modifying antirheumatic ...
via Bing News